Skip to content

Join Us
Members Area

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines
Research

Publication Category: Medications

Antibiotic use in early childhood and risk of obesity: longitudinal analysis of a national cohort

D. Kelly; A. Kelly; T. O’Dowd; C. B. Hayes Antibiotic use in early childhood and risk of obesity: longitudinal analysis of a national cohort World Journal of Pediatrics

Weight-lowering Effects of Glucagon-like Peptide-1 Receptor Agonists and Detection of Breast Cancer Among Obese Women with Diabetes

C. Santella; H. Yin; B. M. Hicks; O. H. Y. Yu; N. Bouganim; L. Azoulay Weight-lowering Effects of Glucagon-like Peptide-1 Receptor Agonists and Detection of Breast Cancer Among Obese Women with Diabetes Epidemiology
Insulin Resistance & Diabetes

Obesity, Aspirin, and Risk of Colorectal Cancer in Carriers of Hereditary Colorectal Cancer: A Prospective Investigation in the CAPP2 Study

M. Movahedi; D. T. Bishop; F. Macrae; J. P. Mecklin; G. Moeslein; S. Olschwang; D. Eccles; D. G. Evans; E. R. Maher; L. Bertario; M. L. Bisgaard; M. G. Dunlop; J. W. Ho; S. V. Hodgson; A. Lindblom; J. Lubinski; P. J. Morrison; V. Murday; R. S. Ramesar; L. Obesity, Aspirin, and Risk of Colorectal Cancer in Carriers of Hereditary Colorectal Cancer: A Prospective Investigation in the CAPP2 Study J Clin Oncol

A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease

R. A. Scott; D. F. Freitag; L. Li; A. Y. Chu; P. Surendran; R. Young; N. Grarup; A. Stancáková; Y. Chen; T. V. Varga; H. Yaghootkar; J. Luan; J. H. Zhao; S. M. Willems; J. Wessel; S. Wang; N. Maruthur; K. Michailidou; A. Pirie; S. J. van der Lee; C. Gills A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease Sci Transl Med
Genetics

Preoperative weight loss with glucagon-like peptide-1 receptor agonist treatment predicts greater weight loss achieved by the combination of medical weight management and bariatric surgery in patients with type 2 diabetes: A longitudinal analysis

T. Tang; S. Abbott; C. W. le Roux; V. Wilson; R. Singhal; S. Bellary; A. A. Tahrani Preoperative weight loss with glucagon-like peptide-1 receptor agonist treatment predicts greater weight loss achieved by the combination of medical weight management and bariatric surgery in patients with type 2 diabetes: A longitudinal analysis Diabetes Obes Metab

Review of multimodal treatment for type 2 diabetes: combining metabolic surgery and pharmacotherapy

A. Sudlow; C. W. le Roux; D. J. Pournaras Review of multimodal treatment for type 2 diabetes: combining metabolic surgery and pharmacotherapy Ther Adv Endocrinol Metab
Insulin Resistance & Diabetes

Thromboembolism, Bleeding, and Mortality Incidence of Direct Oral Anticoagulants Versus Warfarin Postbariatric Surgery

K. Srivastava; N. Patel; M. Tabbara; A. Liew; I. Zaghloul; M. M. Migliore; R. A. Mekary Thromboembolism, Bleeding, and Mortality Incidence of Direct Oral Anticoagulants Versus Warfarin Postbariatric Surgery Am J Med

Copper, selenium and zinc levels after bariatric surgery in patients recommended to take multivitamin-mineral supplementation

D. Papamargaritis; E. T. Aasheim; B. Sampson; C. W. le Roux Copper, selenium and zinc levels after bariatric surgery in patients recommended to take multivitamin-mineral supplementation J Trace Elem Med Biol

Metabolic surgery versus conventional therapy in type 2 diabetes

A. D. Miras; C. W. le Roux Metabolic surgery versus conventional therapy in type 2 diabetes Lancet
Insulin Resistance & Diabetes

Adjunctive liraglutide treatment in patients with persistent or recurrent type 2 diabetes after metabolic surgery (GRAVITAS): a randomised, double-blind, placebo-controlled trial

A. D. Miras; B. Pérez-Pevida; M. Aldhwayan; A. Kamocka; E. R. McGlone; W. Al-Najim; H. Chahal; R. L. Batterham; B. McGowan; O. Khan; V. Greener; A. R. Ahmed; A. Petrie; S. Scholtz; S. R. Bloom; T. M. Tan Adjunctive liraglutide treatment in patients with persistent or recurrent type 2 diabetes after metabolic surgery (GRAVITAS): a randomised, double-blind, placebo-controlled trial Lancet Diabetes Endocrinol
Insulin Resistance & Diabetes

Older posts

Newer posts

← Previous Page1 … Page14 Page15 Page16 … Page18 Next →

Search for:

Recent Posts

9th ASOI Annual Conference – Registration now open!
Press Release for World Obesity Day 4th March 2024
ASOI and ICPO response to : Medical Council Communication: “Important medicine shortage information – Ozempic (semaglutide)”
Things to do in Dublin during ECO
ECO 2023 sponsorship update

ASOI

info@asoi.info

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines
Research

Menu

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines
Research

Privacy Policy
Site Map

©2024 ASOI